BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1006 related articles for article (PubMed ID: 12534602)

  • 1. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
    Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
    Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of lamins depends on epidermal differentiation and transformation.
    Oguchi M; Sagara J; Matsumoto K; Saida T; Taniguchi S
    Br J Dermatol; 2002 Nov; 147(5):853-8. PubMed ID: 12410693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours.
    Hinterhuber G; Cauza K; Dingelmaier-Hovorka R; Diem E; Horvat R; Wolff K; Foedinger D
    Br J Dermatol; 2005 Oct; 153(4):785-9. PubMed ID: 16181461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
    Zhang X; Egawa K; Xie Y; Ihn H
    Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
    de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
    Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P27 and mib1 expression in actinic keratosis, Bowen disease, and squamous cell carcinoma.
    Oh CW; Penneys N
    Am J Dermatopathol; 2004 Feb; 26(1):22-6. PubMed ID: 14726819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of individual lamins in basal cell carcinomas of the skin.
    Venables RS; McLean S; Luny D; Moteleb E; Morley S; Quinlan RA; Lane EB; Hutchison CJ
    Br J Cancer; 2001 Feb; 84(4):512-9. PubMed ID: 11207047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
    Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
    J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan, CD44 and versican in epidermal keratinocyte tumours.
    Karvinen S; Kosma VM; Tammi MI; Tammi R
    Br J Dermatol; 2003 Jan; 148(1):86-94. PubMed ID: 12534600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elevated p53 protein expression in normal and neoplastic light-exposed epidermis].
    Sutter C; Wersin R; Varnai M; Friemann J
    Verh Dtsch Ges Pathol; 1994; 78():246-51. PubMed ID: 7533993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma.
    Dang C; Gottschling M; Roewert J; Forschner T; Stockfleth E; Nindl I
    Br J Dermatol; 2006 Oct; 155(4):763-70. PubMed ID: 16965426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cell proliferation in benign, premalignant and malignant skin lesions.
    Bordbar A; Dias D; Cabral A; Beck S; Boon ME
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):229-35. PubMed ID: 17525640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Less expression of cyclin E in cutaneous squamous cell carcinomas than in benign and premalignant keratinocytic lesions.
    Bito T; Ueda M; Ito A; Ichihashi M
    J Cutan Pathol; 1997 May; 24(5):305-8. PubMed ID: 9194584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Podoplanin in Non-melanoma Skin Cancers and Actinic Keratosis.
    Wojciechowska-Zdrojowy M; Szepietowski JC; Matusiak Ł; Dzięgiel P; Puła B
    Anticancer Res; 2016 Apr; 36(4):1591-7. PubMed ID: 27069135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin.
    Stelkovics E; Kiszner G; Meggyeshazi N; Korom I; Varga E; Nemeth I; Molnar J; Marczinovits I; Krenacs T
    Histol Histopathol; 2013 Jul; 28(7):941-54. PubMed ID: 23446646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin.
    Lavrijsen AP; Tieben LM; Ponec M; van der Schroeff JG; van Muijen GN
    Arch Dermatol Res; 1989; 281(2):83-8. PubMed ID: 2476080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin expression in normal skin and non-melanoma skin tumors.
    Chang PL; Harkins L; Hsieh YH; Hicks P; Sappayatosok K; Yodsanga S; Swasdison S; Chambers AF; Elmets CA; Ho KJ
    J Histochem Cytochem; 2008 Jan; 56(1):57-66. PubMed ID: 17938278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.